全内镜二尖瓣手术中同期左侧冷冻消融的长期结局
本研究回顾性分析2016至2023年123例全内镜二尖瓣手术同期行左侧冷冻消融患者,基于24小时动态心电图随访。中位随访36.0个月,房颤复发率8.43/100患者年,1、3、5年免于房颤率分别为96.6%、86.3%、69.4%,房颤类型和左房容积为复发预测因素。
要点
- 全内镜二尖瓣手术同期左侧冷冻消融安全,无消融相关并发症。
- 5年免于房颤复发率为69.4%,长期效果可接受。
- 房颤类型和左房容积是房颤复发的独立预测因素。
核心结论
- 全内镜二尖瓣手术同期左侧冷冻消融是治疗房颤安全有效的方法,鼓励的长期结果支持在全内镜二尖瓣手术中考虑该术式。
研究设计与样本
- 回顾性研究,纳入2016至2023年在本中心接受全内镜二尖瓣手术同期左侧冷冻消融的患者,基于24小时动态心电图随访数据分析,共123例。
主要发现
- 中位随访36.0个月(四分位距17-60),记录到34次房颤复发,复发率8.43/100患者年(95%CI 5.90-11.73)。
- 估计1年、3年、5年免于房颤率分别为96.6%、86.3%、69.4%。
- 未观察到消融相关并发症。
关键数值与推荐
- 全内镜二尖瓣手术同期左侧冷冻消融可作为房颤治疗策略,长期免于房颤率1年96.6%、3年86.3%、5年69.4%。
临床怎么用
- 在全内镜二尖瓣手术中可考虑同期行左侧冷冻消融以治疗房颤,术后需根据房颤类型和左房容积评估复发风险并加强随访。
局限性
- 回顾性单中心研究,样本量123例,随访数据基于24小时动态心电图,可能低估复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Concomitant atrial fibrillation ablation is a well-established procedure in patients undergoing mitral valve (MV) surgery. However, data concerning the long-term outcomes of cryoablation performed during totally endoscopic MV surgery remain limited. Furthermore, different lesion sets and energy sources used in endoscopic approach may result in varying outcomes. We therefore, analysed rhythm outcome in patients undergoing left-sided cryoablation during totally endoscopic MV surgery. METHODS: Patients, who underwent totally endoscopic MV surgery with concomitant left-sided cryoablation between 2016 and 2023 at our centre were included in the study. The retrospective data analysis was based on 24-h Holter monitor follow-up data. RESULTS: A total of 123 patients were included in the study. No complications related to the ablation procedure were observed. The median follow-up period was 36.0 (interquartile range: 17-60) months. During this period, 34 episodes of atrial fibrillation recurrence were documented, corresponding to a recurrence rate of 8.43 per 100 patient-years (95% confidence interval: 5.90-11.73). The estimated freedom from AF at 1, 3, and 5 years were 96.6%, 86.3%, and 69.4% respectively. Type of atrial fibrillation (P = .004; hazard ratio [HR]: 2.521; 95% confidence interval [CI]: 1.347-4.716) and left atrial volume (P = .003; HR: 1.010; 95% CI: 1.003-1.016) were identified as predictors for atrial fibrillation recurrence. CONCLUSIONS: Concomitant left-sided cryoablation during totally endoscopic MV surgery is a safe and effective procedure for atrial fibrillation treatment. The encouraging long-term outcomes support the consideration of this approach in totally endoscopic mitral surgery.
引用
- Bazhanov I, Petersen J, Yildirim Y, et al. Long-Term Outcomes of Concomitant Left-Sided Cryoablation During Totally Endoscopic Mitral Valve Surgery. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 41014495. doi:10.1093/icvts/ivaf217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。